Neuroinflammation, the accompanying amyloid plaque
Post# of 148286
(Total Views: 699)
Posted On: 06/11/2020 6:31:45 PM
Re: Rubraquercus #37441
Neuroinflammation, the accompanying amyloid plaques and damage to microglial cells are caused by an overreaction of RANTES (CCL5).
CCL5 does have a protective benefit by mediating glutamate release. CCR5 is the predominate receptor, CCL5 also binds to CCR1 and CCR3. CCR1, CCR3 and GPR75 have a lesser binding affinity for CCR5 and are expressed at a much lower level than CCR5. Thus you have a low level of CCL5 activity that allows neuroprotective glutamate mediation without the damaging inflammation.
With MCP-1 (CCL2) that is mentioned in the article which is neuroprotective (and also helps kill tumor cells) that binds to CCR2 so CCR5 blockade is not an issue.
CCL5 does have a protective benefit by mediating glutamate release. CCR5 is the predominate receptor, CCL5 also binds to CCR1 and CCR3. CCR1, CCR3 and GPR75 have a lesser binding affinity for CCR5 and are expressed at a much lower level than CCR5. Thus you have a low level of CCL5 activity that allows neuroprotective glutamate mediation without the damaging inflammation.
With MCP-1 (CCL2) that is mentioned in the article which is neuroprotective (and also helps kill tumor cells) that binds to CCR2 so CCR5 blockade is not an issue.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼